Sign In
to Vote &
Create Storyboards.
 

Market News

Location American Market News for 5 December 2019
Anti-Theranos: FDA Approval In Hand, Sight Diagnostics Aims At $2.7 Billion Blood Testing Giant, Sysmex Sysmex, a $2.5 billion Japanese maker of blood testing machines, is in the cross-hairs of Sight Diagnostics, an Israeli company that just received FDA approval for a blood tester that requires only two drops of blood.
Read More
4
0

Meet Wall Street's Rent Collector

Wall Street Journal - 5 Dec 2019 15:00
Redwood Trust, one of Wall Street's biggest bundlers of mortgage bonds, has moved into rentals.
Read More
4
0

Treasury to Sell $156 Billion of Debt

Wall Street Journal - 5 Dec 2019 23:49
The U.S. Treasury Department's auctions next week will range from 13-week bills to 30-year bonds.
Read More
3
0
Prices for a rare metal used to filter emissions in gasoline car engines continue rising, defying predictions that substitution of a cheaper alternative by auto makers would halt a yearslong rally.
Read More
2
0

New Shopping Habits May Help Gucci's Owner

Wall Street Journal - 5 Dec 2019 17:34
If Louis Vuitton is about to pair up with Tiffany, what should Gucci do? A big acquisition by the Italian brand's owner could be a helpful shift in strategy.
Read More
1
0

Why 10X Genomics Has Rallied Post Its IPO

Forbes - 5 Dec 2019 17:00
Why 10X Genomics Has Rallied Post Its IPO 10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post its debut, it currently tr...
Read More
1
0
This Stock Is The This industry is flirting with new all-time highs. A "breakout" here would lead to much higher stock prices. And I believe it's only a matter of time before that happens.
Read More
1
0

MetLife Expands into Fast-Growing Sector: Pet Insurance

Wall Street Journal - 5 Dec 2019 14:00
MetLife's purchase of Indiana-based PetFirst is the latest sign of the insurance industry's efforts to rev up revenue amid sluggish sales of individual life-insurance policies.
Read More
1
0

Stocks to Watch: Slack, H&R Block, At Home Group, Five Below

Wall Street Journal - 5 Dec 2019 12:09
Here are some of the companies with shares expected to trade actively Thursday.
Read More
1
0

Zoom shares slide as growth slows

CNBC - 5 Dec 2019 23:13
Zoom's revenue grew 85% in the quarter as growth kept slowing sequentially.
Read More
0
0
Elizabeth Warren Reportedly Drafting Bill To Ban 'Mega Mergers' It's not the first time the senator has gone after big business.
Read More
0
0

OPEC Agrees to Deeper Cuts Ahead of Aramco IPO

Wall Street Journal - 5 Dec 2019 22:37
OPEC agreed to deepen curbs on crude output by about 40% next year, as Saudi Arabia pushes for higher oil prices amid the initial public offering of its state-controlled oil company.
Read More
0
0

Twitter Poised to Sell Bonds at Low Interest Rate

Wall Street Journal - 5 Dec 2019 21:24
Twitter is poised to sell its first-ever conventional bonds at a lower interest rate than initially expected, a sign of robust demand from investors drawn to the social-media company's ample cash flow.
Read More
0
0
Art Of The Deal - How Donald Trump Is Saving The Euro Donald Trump is doing enough to make the EU realise that it is on its own, and that the euro needs to be stronger
Read More
0
0

A Norwegian-Argentine Union that Wasn't Meant to Be

Wall Street Journal - 5 Dec 2019 20:09
Norwegian Air Shuttle has sold its Argentine subsidiary, which was always an unlikely gamble on a remote market.
Read More
0
0

Pick Up Kroger on Sale

Wall Street Journal - 5 Dec 2019 20:01
The grocer's shares remain cheap even as its sales growth is accelerating.
Read More
0
0

Three Dividend Tech Picks For 2020

Forbes - 5 Dec 2019 20:00
Three Dividend Tech Picks For 2020 Investors searching for yield in a low-interest-rate environment should take a close look at three technology leaders -- Cisco, Taiwan Semi, and Texas Instruments.
Read More
0
0

Safety and Biotech Investing Don't Mix

Wall Street Journal - 5 Dec 2019 19:58
Sage Therapeutics' clinical-trial blowup should remind biotech investors that even the healthiest-looking stock is at risk.
Read More
0
0
How Does F5 Networks Primarily Make Money: Product Sales or Services? F5 Networks (NASDAQ: FFIV) makes money through the sale of networking and security offerings. The company's stock has been upbeat since it announced the acquisition of NGNIX in March. NGNIX was a key competitor to F5 in ...
Read More
0
0
2 Cheap Stocks You Need To Buy By The End Of 2019 Thinking of doing some end-of-year stock shopping? If the answer is "yes," you might want to give these mega-cheap shares some attention.
Read More
0
0

Slack Gets Ahead of the News

Wall Street Journal - 5 Dec 2019 19:12
At least give Slack Technologies credit for not ignoring the elephant in the room. And Microsoft is an awfully big elephant.
Read More
0
0
Why Urban Outfitters' Stock Looks Undervalued Urban Outfitters' (NASDAQ: URBN) stock has lost nearly 20% of its value over recent weeks primarily because the company fell short of consensus estimates on earnings and revenues for its Q3 results. However, we believe t...
Read More
0
0

{TITLE}

{PUBLISHER} - {PUBLISHED_DATE}
{TITLE} {CONTENT}
Read More
{VIEWS}
0


Storyboard
Print
{VIEWS}
0
0




Share this Article

Location



Create Storyboard